Author

Zhiqiang Hu

Sensetime (China)ORCID 0000-0003-0830-815XUnclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Zhiqiang Hu2 papers · Shanghai Jiao Tong University

Biology Disciplines

Click to filter author papers

Bioinformatics· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 2 Research Focus:drug response / drug discovery· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Mu ZhouiD· 2 shared Guofeng Lyu· 1 shared Qiao LiuiD· 1 shared Rui JiangiD· 1 shared Shaoting ZhangiD· 1 shared Yanguang BiiD· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 9 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioinformatics

Mu ZhouORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioinformaticsbioRxivPreprintNov 23, 2022

Dynamic Interaction Learning and MultimodalRepresentation for Drug Response Prediction

Yanguang Bi, Mu Zhou, Zhiqiang Hu…·Guofeng Lyu

This paper introduces a dynamic interaction learning network for drug response prediction, achieving high AUC scores on drug-protein interaction and cancer drug response tasks.

1 citation

proteomicsdeep learning

𝕏 PostBluesky

BioinformaticsBioinformaticsPeer-reviewedOct 12, 2020

DeepCDR: a hybrid graph convolutional network for predicting cancer drug response

Qiao Liu, Zhiqiang Hu, Rui Jiang, Mu Zhou

DeepCDR predicts cancer drug response by integrating multi-omics data and drug chemical structures using a hybrid graph convolutional network, outperforming existing methods.

266 citationstop 1%

humanbulk RNA-seq

𝕏 PostBluesky